Misoprostol, a synthetic prostaglandin El analog, is effective in treating and preventing nonsteroidal antiinflammatory drug (NSAI D)-induced gastrointestinal lesions in humans. The effectiveness of misoprostol in preventing aspirin-induced gastroduodenal injury was studied in 3 groups of 6 adult mixed breed dogs. Group I received 3 Fg/ kg misoprostol PO tid. Group II received 3 pg/kg misoprosto1 PO tid and 35 mg/kg aspirin PO tid. Group Ill received 35 mg/kg aspirin PO tid. Endoscopy was performed on days 0, 5, 14, and 30. Five regions of the upper gastrointestinal tract were qualitatively scored from 1 to 1 2 based on the presence of submucosal hemorrhage, erosion, or ulceration, with ulceration receiving a higher numerical score than submucosal hemorrhage. A total score was assigned based on the sum of the scores from all regions.onsteroidal antiinflammatory drugs (NSAIDs) N are frequently used for treating degenerative joint disease. Side effects of NSAID therapy in the dog include gastrointestinal bleeding and ulceration, and inhibition of platelet Aspirin causes gastrointestinal damage in a dose-dependent fashion and has been shown to cause gastrointestinal bleeding in dogs at the clinically recommended dose of 25 to 35 mg/kg.3-5 The prevalence of serious gastrointestinal complications (ulceration with perforation, severe bleeding) for dogs is unknown, but is estimated at 1 per 5,500 in humans treated with NSAIDs for longer than 1 month.6 More than 10% of human patients receiving NSAIDs chronically have an ulcer at any given The mechanism of aspirin-induced gastrointestinal damage is controversial, but is thought to